High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia

BACKGROUND: Nephrotoxicity is an important adverse effect of colistin methanesulfonate (CMS) therapy. No data exist on rates and risk factors for colistin-related nephrotoxicity in Saudi Arabia (SA). We conducted a prospective cohort study to identify rates and risk factors for CMS nephrotoxicity in...

Descripción completa

Detalles Bibliográficos
Autores principales: Omrani, Ali S, Alfahad, Wafa A, Shoukri, Mohamed M, Baadani, Abeer M, Aldalbahi, Sultan, Almitwazi, Ali A, Albarrak, Ali M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301664/
https://www.ncbi.nlm.nih.gov/pubmed/25591721
http://dx.doi.org/10.1186/s12941-015-0062-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301664/
https://www.ncbi.nlm.nih.gov/pubmed/25591721
http://dx.doi.org/10.1186/s12941-015-0062-8

Ejemplares similares